VRCA Live signals | Maximize Profits with Getagraph.com

BUY 105615 min ago

@ $5.55

Issued: 13 Feb 2024 @ 10:00

Return: 23.90%

Previous signal: Feb 9 - 11:12

Previous signal: Sell

Return: 2.31 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States...

Stats
Today's Volume	110 101
Average Volume	138 391
Market Cap	291.43M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.530 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.64
ATR14	$0.0150 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Hayes Christopher G.	Buy	40 000	Common Stock
2024-03-15	Hayes Christopher G.	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Goldenberg Gary	Buy	40 000	Common Stock
2024-03-15	Goldenberg Gary	Buy	80 000	Employee Stock Option (right to buy)
2024-03-15	Kohler Terry	Buy	80 000	Employee Stock Option (right to buy)

INSIDER POWER
91.03
Last 98 transactions
Buy: 14 420 498 \| Sell: 288 608

Volume Correlation

Long: -0.12 (neutral)

Short: -0.33 (neutral)

Signal:(50.133) Neutral

Verrica Pharmaceuticals Correlation

10 Most Positive Correlations
TGTX	0.959
IDCC	0.956
SLMBP	0.955
VBOCU	0.955
RAM	0.95
WKEY	0.95
OVLY	0.948
NCAC	0.947
MESA	0.946
GPACU	0.945

10 Most Negative Correlations
CBNK	-0.945
CYTO	-0.939
GSMG	-0.938
GNTY	-0.936
BFRI	-0.936
FGBI	-0.936
GOOD	-0.934
AMNB	-0.93
CMLS	-0.929
ALHC	-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verrica Pharmaceuticals Correlation - Currency/Commodity

0.36
( neutral )

0.63
( weak )

0.00
( neutral )

0.11
( neutral )

0.00
( neutral )

-0.72
( moderate negative )

Verrica Pharmaceuticals Financials

Annual	2023
Revenue:	$5.12M
Gross Profit:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2023
Revenue:	$5.12M
Gross Profit:	$3.96M (77.28 %)
EPS:	$-1.480

FY	2022
Revenue:	$9.03M
Gross Profit:	$8.31M (91.97 %)
EPS:	$-0.810

FY	2021
Revenue:	$12.00M
Gross Profit:	$12.00M (100.00 %)
EPS:	$-1.300

Financial Reports:

No articles found.

Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.